Constellation Pharmaceuticals

Constellation Pharmaceuticals is a Clinical Stage Biopharmaceutical company. The company using expertise in epigenetics to discover and develop novel therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression. It is integrated epigenetics platform includes a deep understanding of the biological context in which epigenetic regulatory proteins or epigenetic regulators, operate the development of small molecule product candidates that selectively modulate their activity and the design of clinical development programs supported by novel biomarker strategies. The headquarters is in USA.